Loomis Sayles & Co. L P Purchases 20,688 Shares of Integer Holdings Co. (NYSE:ITGR)

Loomis Sayles & Co. L P boosted its holdings in shares of Integer Holdings Co. (NYSE:ITGR) by 3.8% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 558,715 shares of the medical equipment provider’s stock after buying an additional 20,688 shares during the period. Loomis Sayles & Co. L P owned about 1.67% of Integer worth $74,041,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently bought and sold shares of the business. Jane Street Group LLC increased its stake in Integer by 23.3% in the third quarter. Jane Street Group LLC now owns 151,397 shares of the medical equipment provider’s stock valued at $19,682,000 after acquiring an additional 28,572 shares during the period. Verition Fund Management LLC raised its holdings in shares of Integer by 17.4% in the 3rd quarter. Verition Fund Management LLC now owns 3,470 shares of the medical equipment provider’s stock worth $451,000 after buying an additional 515 shares in the last quarter. Versant Capital Management Inc lifted its position in shares of Integer by 98.4% during the 4th quarter. Versant Capital Management Inc now owns 369 shares of the medical equipment provider’s stock worth $49,000 after buying an additional 183 shares during the period. KBC Group NV boosted its stake in Integer by 83.3% in the 4th quarter. KBC Group NV now owns 1,598 shares of the medical equipment provider’s stock valued at $212,000 after buying an additional 726 shares in the last quarter. Finally, Lord Abbett & CO. LLC grew its position in Integer by 3.5% in the third quarter. Lord Abbett & CO. LLC now owns 290,120 shares of the medical equipment provider’s stock valued at $37,716,000 after acquiring an additional 9,754 shares during the period. Institutional investors own 99.29% of the company’s stock.

Wall Street Analyst Weigh In

A number of research analysts have issued reports on ITGR shares. KeyCorp lifted their price objective on Integer from $144.00 to $154.00 and gave the company an “overweight” rating in a report on Friday, January 24th. Wells Fargo & Company restated an “overweight” rating and issued a $160.00 price target on shares of Integer in a research report on Tuesday, December 3rd. Benchmark lifted their target price on shares of Integer from $140.00 to $150.00 and gave the company a “buy” rating in a research note on Friday, February 21st. Oppenheimer cut Integer from an “outperform” rating to a “market perform” rating in a research note on Friday, February 21st. Finally, Citigroup upped their price target on Integer from $130.00 to $145.00 and gave the company a “neutral” rating in a research note on Wednesday, December 11th. Two research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $149.00.

Integer Trading Down 0.8 %

NYSE:ITGR opened at $118.13 on Thursday. The business’s 50-day simple moving average is $131.40 and its 200-day simple moving average is $132.12. Integer Holdings Co. has a fifty-two week low of $107.11 and a fifty-two week high of $146.36. The company has a debt-to-equity ratio of 0.62, a current ratio of 2.95 and a quick ratio of 2.09. The stock has a market capitalization of $3.97 billion, a PE ratio of 35.16, a price-to-earnings-growth ratio of 1.72 and a beta of 1.24.

Integer (NYSE:ITGR) last released its quarterly earnings results on Thursday, February 20th. The medical equipment provider reported $1.43 earnings per share for the quarter, missing the consensus estimate of $1.46 by ($0.03). Integer had a net margin of 6.92% and a return on equity of 11.65%. The company had revenue of $449.50 million during the quarter, compared to analyst estimates of $446.28 million. Sell-side analysts expect that Integer Holdings Co. will post 6.01 earnings per share for the current fiscal year.

Integer Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.